Farnesyltransferase and geranylgeranyltransferase I: structures, mechanism, inhibitors and molecular modeling

Drug Discov Today. 2015 Feb;20(2):267-76. doi: 10.1016/j.drudis.2014.10.002. Epub 2014 Oct 16.

Abstract

Farnesyltransferase (FTase) and geranylgeranyltransferase type I (GGTase-I) have crucial roles in the post-translational modifications of Ras proteins and, therefore, they are promising therapeutic targets for the treatment of various Ras-induced cancers and several other kinds of diseases. In this review, we provide an overview of the structures and biological functions of FTase and GGTase-I. Then, we summarize the typical inhibitors of FTase and GGTase-I, and highlight the drug candidates in clinical trials. In addition, we survey some recent advances in computer-aided drug design (CADD) and molecular modeling studies of FTase and GGTase-I.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alkyl and Aryl Transferases* / antagonists & inhibitors
  • Alkyl and Aryl Transferases* / chemistry
  • Alkyl and Aryl Transferases* / metabolism
  • Animals
  • Farnesyltranstransferase* / antagonists & inhibitors
  • Farnesyltranstransferase* / chemistry
  • Farnesyltranstransferase* / metabolism
  • Humans
  • Models, Molecular
  • Protein Conformation

Substances

  • Alkyl and Aryl Transferases
  • geranylgeranyltransferase type-I
  • Farnesyltranstransferase